Skip to content
2000
Volume 5, Issue 8
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

The SHAPES strategy combines nuclear magnetic resonance (NMR) screening of a library of small drug-like molecules with a variety of complementary methods, such as virtual screening, high throughput enzymatic assays, combinatorial chemistry, X-ray crystallography, and molecular modeling, in a directed search for new medicinal chemistry leads. In the past few years, the SHAPES strategy has found widespread utility in pharmaceutical research. To illustrate a variety of different implementations of the method, we will focus in this review on recent applications of the SHAPES strategy in several drug discovery programs at Vertex Pharmaceuticals.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207023329950
2002-12-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207023329950
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test